Key result
Metabolically healthy obesity prevalence varies up to ~35% by criteria, with elevated adiponectin in women.
Why the study?
The prevalence of metabolically healthy obesity phenotypes and their association with adipokine levels among Saint-Petersburg inhabitants were unclear.
Population
1600 Saint-Petersburg inhabitants stratified by gender and age including 430 with obesity
Comparison
Metabolically healthy obesity vs metabolically unhealthy obesity phenotypes
Design
Cross-sectional epidemiologic study
Authors
Loading...
Variable MHO prevalence by criteria should not change practice; supports adiponectin research for phenotyping obese women.
Cross-Sectional (n=1,600)
No
The definition of metabolically healthy obesity significantly impacts its reported prevalence, and adiponectin levels may help differentiate metabolic profiles in obese women.
Boyarinova et al. (2016) conducted a cross-sectional in Metabolically healthy obesity (n=1,600). Metabolically healthy obesity (MHO) vs. Metabolically unhealthy obesity (MUHO) was evaluated on Prevalence of metabolically healthy obesity (MHO) according to different criteria. The prevalence of metabolically healthy obesity among 430 obese individuals varied from 12% to 35% depending on the diagnostic criteria used, with elevated adiponectin observed in MHO women.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: